Fruquintinib in the Treatment of Soft Tissue Sarcoma

Status:
Recruiting

Trial end date:
2023-08-30

Target enrollment:

Participant gender:

To evaluate the efficacy of Fruquintinib in patients with chemotherapy insensitive or chemotherapy resistant soft tissue sarcoma

Phase 2

Fudan University